Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR5A2 |
| Upstream (Parents) |
|---|
| (<<) VTN → NR5A2 |
| (<<) HLF → NR5A2 |
| (<<) NR1I3 → NR5A2 |
| (<<) SALL1 → NR5A2 |
| (<<) NR1H4 → NR5A2 |
| (<<) ONECUT1 → NR5A2 |
| (<<) AR → NR5A2 |
| (<<) SOX9 → NR5A2 |
| (<<) CSDA → NR5A2 |
| Downstream (Children) |
|---|
| NR5A2 → ASCL2 (>>) |
| NR5A2 → SOX11 (>>) |
| NR5A2 → HNF4A (>>) |
| NR5A2 → ARNT2 (>>) |
| NR5A2 → TFAP2A (>>) |
| NR5A2 → TSHZ2 (>>) |
| NR5A2 → MAF (>>) |
| NR5A2 → LEF1 (>>) |
| NR5A2 → HOXB7 (>>) |
| NR5A2 → NR2F6 (>>) |
| NR5A2 → BARX1 (>>) |
| NR5A2 → MSX1 (>>) |
| NR5A2 → NR1I2 (>>) |
| NR5A2 → CREB3L1 (>>) |
| NR5A2 → HNF1A (>>) |
| NR5A2 → PROX1 (>>) |
| NR5A2 → EPAS1 (>>) |
| NR5A2 → ZFHX4 (>>) |
| NR5A2 → CITED2 (>>) |
| NR5A2 → NR2C1 (>>) |
